Business Context and Reporting Period
This Form 8-K Current Report was filed by iSpecimen Inc. (Nasdaq: ISPC) on November 7, 2025. The filing discloses significant changes to the Company's executive leadership and Board of Directors effective immediately.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and personnel changes rather than financial performance.
Material Changes
- Executive Leadership: Ms. Katharyn Field was appointed Chief Executive Officer, Secretary, and Treasurer. She continues to serve as President. Mr. Robert Bradley Lim stepped down from all executive roles and resigned from the Board.
- Board Composition: Mr. Arphing (Tommy) Lee was appointed as an independent director to fill the vacancy left by Mr. Lim. He was also appointed to the Audit Committee and the Nominating and Corporate Governance Committee.
- Committee Updates: The Audit Committee now includes Mr. Lee, with Mr. Anthony Lau as Chair. The Nominating and Corporate Governance Committee now includes Mr. Lee, with Mr. Dhaliwal as Chair.
Management Commentary and Outlook
Management stated that the Board and team remain focused on executing the Company's objectives and do not anticipate any disruption to operations resulting from these leadership changes. The filing notes that Mr. Lim's resignation did not involve a disagreement with the Company regarding operations, policies, or practices. There were no changes to Ms. Field's compensation in connection with her appointment.
Investor Verification Checklist
- Verify the effective date of Ms. Field's appointment as CEO and Mr. Lim's resignation (November 7, 2025).
- Confirm the new composition of the Audit and Nominating and Corporate Governance Committees.
- Review Ms. Field's background in the cannabis and strategy consulting sectors as disclosed in the filing.
- Monitor future filings for details on broader management and director succession planning mentioned by the Board.